Drug policy, values and the public health approach – four lessons from drug policy reform movements : Nordic Studies on Alcohol and Drugs

www.degruyter.com uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience.
To understand more about cookies, tags, and tracking, see our Privacy Statement
I accept all cookies for the De Gruyter Online site

Jump to ContentJump to Main Navigation

Nordic Studies on Alcohol and Drugs

The Journal of Nordic Centre for Welfare and Social Issues


IMPACT FACTOR 2014: 0.564

SCImago Journal Rank (SJR) 2014: 0.176
Source Normalized Impact per Paper (SNIP) 2014: 0.278
Impact per Publication (IPP) 2014: 0.257

Open Access
VolumeIssuePage

Drug policy, values and the public health approach – four lessons from drug policy reform movements

1Ragnar Frisch Centre for Economic Research

© Ole Rogeberg. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Citation Information: Nordic Studies on Alcohol and Drugs. Volume 32, Issue 4, Pages 347–364, ISSN (Online) 1458-6126, DOI: 10.1515/nsad-2015-0034, September 2015

Publication History

Received:
2015-03-10
Accepted:
2015-04-14
Published Online:
2015-09-19

Abstract

Drug policies affect a large set of outcomes and may reflect the concerns of several policy stakeholder groups. Researchers analysing policies typically employ a public health approach, extended to reflect concerns beyond population health and longevity. I argue that the resulting approach, as currently practised, fails to capture several concerns seen as important by recent drug policy reform movements, that is, the full harms of illegal markets, the subjectively valued consumption of intoxicants, the dysfunctionality of current policy processes in the drug field and the value of the knowledge gained from policy experiments. I illustrate this by referring to the book Drug policy and the public good, a public health-based review of research evidence and its relevance for drug policy written by leading international researchers in the field.

REFERENCES

  • Adda, J., McConnell, B., & Rasul, I. (2014). Crime and the depenalization of cannabis possession: Evidence from a policing experiment. Journal of Political Economy, 122(5), 1130–1202. [Web of Science] [CrossRef]

  • Anderson, D. M., Hansen, B., & Rees, D. I. (Forthcoming). Medical marijuana laws and teen marijuana use. American Law and Economics Review.

  • Anderson, D. M., Hansen, B., & Rees, D. I. (2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. Journal of Law and Economics, 56(2), 333–369. [Web of Science]

  • Anderson, D. M., Rees, D. I., & Sabia, J. J. (2014). Medical marijuana laws and suicide by gender and age.” American Journal of Public Health, 104(12), 2369–2376. [CrossRef]

  • Angrist, J. D., & Kugler, A. D. (2008). Rural windfall or a new resource curse? Coca, income, and civil conflict in Colombia. Review of Economics and Statistics, 90(2), 191–215. [Web of Science] [CrossRef]

  • Babor, T. (2010). Drug policy and the public good. Oxford: Oxford University Press.

  • Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010.” JAMA Internal Medicine, 174(10), 1668–1673. [Web of Science]

  • Brownfield, W. R. (2014). Trends in global drug policy. US Department of State. The Office of Electronic Information. U.S. Department of State. October 9. http://fpc.state.gov/232813.htm#.VD1Vud9x8L0.twitter.

  • Caulkins, J. P., Hawken, A., Kilmer, B., & Kleiman, M. A. R. (2012). Marijuana legalization: What everyone needs to know. Oxford University Press.

  • Caulkins, J. P., Pacula, R. L., Paddock, S. M., & Chiesa, J. (2002). School-based drug prevention: What kind of drug use does it prevent? RAND Corporation. http://www.rand.org/pubs/monograph_reports/MR1459.html.

  • Chu, Y-W. L. (Forthcoming). Do medical marijuana laws increase hard drug use? Journal of Law and Economics.

  • CSDP. (2002). Nixon tapes show roots of marijuana prohibition: Misinformation, culture wars, prejudice. CSDP Research Report. Common Sense for Drug Policy. http://www.csdp.org/research/shafernixon.pdf.

  • Dell, M. (Forthcoming). Trafficking networks and the Mexican drug war. American Economic Review. [Web of Science]

  • Drug pleasure ratings. (2015). Accessed March 9. http://www.globaldrugsurvey.com/factsfigures/the-net-pleasure-index-results/.

  • Drug use, privacy and personal choice | Drug Policy Alliance. (2015). Accessed February 21. http://www.drugpolicy.org/drug-use.

  • Fong, G. T., Hammond, D., Laux, F. L., Zanna, M. P., Cummings, K. M., Borland, R., & Ross, H. (2004). The near-universal experience of regret among smokers in four countries: Findings from the International Tobacco Control Policy Evaluation Survey. Nicotine & Tobacco Research, 6(Suppl 3), S341–S351. [CrossRef]

  • Gavrilova, E., Kamada, T., & Zoutman, F. T. (2014). Is legal pot crippling Mexican drug trafficking organizations? The effect of medical marijuana laws on US crime. SSRN Scholarly Paper ID 2350101. Rochester, NY: Social Science Research Network.

  • General Secretariat. (2013). The drug problem in the Americas. Organization of American States.

  • Global Commission on Drug Policy. (2014). Taking control: Pathways to drug policies that work. Global Commission on Drug Policy.

  • Harper, S., Strumpf, E. C., & Kaufman, J. S. (2012). Do medical marijuana laws increase marijuana use? Replication study and extension. Annals of Epidemiology, 22(3), 207–212. [CrossRef] [Web of Science]

  • Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, January, 0269881114565653. [CrossRef] [Web of Science]

  • ITC Project. (2014). ITC Uruguay national report. Findings from the Wave 1 to 4 surveys (2006–2012). University of Waterloo, Waterloo, Ontario, Canada; Centro de Investigación para la Epidemia del Tabaquismo and Universidad de la República, Uruguay.

  • Johansen, P-Ø., & Krebs, T. S. (2015). Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology, 29(3), 270–279. [CrossRef] [Web of Science]

  • Kerr, W. C., & Greenfield, T. K. (2007). Distribution of alcohol consumption and expenditures and the impact of improved measurement on coverage of alcohol sales in the 2000 National Alcohol Survey. Alcoholism: Clinical and Experimental Research, 31(10), 1714–1722. [Web of Science]

  • Krebs, T. S., & Johansen, P-Ø. (2013). Psychedelics and mental health: A population study. PLoS ONE, 8(8): e63972.

  • Light, M. K., Orens, A., Lewandowski, B., & Pickton, T. (2014). Market size and demand for marijuana in Colorado. Colorado, USA: Colorado Department of Revenue.

  • MacCoun, R., & Reuter, P. (2008). The implicit rules of evidence-based drug policy: A US perspective. International Journal of Drug Policy, 19(3), 231–232. [CrossRef]

  • Morris, R. G., TenEyck, M., Barnes, J. C., & Kovandzic, T. V. (2014). The effect of medical marijuana laws on crime: Evidence from State Panel Data, 1990–2006. PLoS ONE, 9(3): e92816.

  • Nutt, D. J., Phillips, L. D., Balfour, D., Curran, H. V., Dockrell, M., Foulds, J., Fagerstrom, K., Letlape, K., Milton, A., & Polosa, R. (2014). Estimating the harms of nicotinecontaining products using the MCDA approach. European Addiction Research, 20(5), 218–225. [Web of Science] [CrossRef]

  • Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369(9566), 1047–1053. [Web of Science]

  • Pacula, R. L., Powell, D., Heaton, P., & Sevigny, E. L. (2013). Assessing the effects of medical marijuana laws on marijuana and alcohol use: The devil is in the details. Working Paper 19302. National Bureau of Economic Research.

  • Palali, A., & van Ours, J. C. (2014). Cannabis use and support for cannabis legalization. No. 2014-027. CentER Discussion Paper. Tilburg University.

  • Rhodes, T., & Hedrich, D. (Eds.). (2010). Harm reduction: Evidence, impacts and challenges. Office for Official Publications of the European Communities.

  • Room, R. (2014). Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. Addiction, 109(3): 345–351. [Web of Science] [CrossRef]

  • Scenario Team. (2013). Scenarios for the Drug problem in the Americas 2013–2025. Organization of American States.

  • Silver, N. (2009). Why marijuana legalization is gaining momentum. FiveThirtyEight. April 5. http://fivethirtyeight.com/features/why-marijuana-legalization-is-gainingmomentum/.

  • Silver, N. (2010). Are parents just saying no to marijuana legalization? FiveThirtyEight. November 10. http://fivethirtyeight.com/features/are-parents-just-saying-no-tomarijuana-legalization/.

  • Smith, L. (2012). The moment: Wild, poignant, life-changing stories from 125 writers and artists famous & obscure. New York: Harper Perennial.

  • Wen, H., Hockenberry, J., & Cummings, J. R. (2014). The effect of medical marijuana laws on marijuana, alcohol, and hard drug use. Working Paper 20085. National Bureau of Economic Research.

  • WHO. (2015). Public Health. WHO. Accessed February 20. http://www.who.int/trade/glossary/story076/en/.

  • Williams, J., van Ours, J. C., & Grossman, M. (2011). Why do some people want to legalize cannabis use? Working Paper 16795. National Bureau of Economic Research. http://www.nber.org/papers/w16795.

Comments (0)

Please log in or register to comment.